TRAIL对人卵巢癌SKOV3细胞生长及凋亡的影响被引量：8

TRAIL Impacts in Growth and Apoptosis of Human Ovarian Carcinoma Cell Line SKOV3

下载PDF

导出

摘要目的研究TRAIL对卵巢癌SKOV3细胞生长及凋亡的影响。同时了解化疗药物对TRAIL受体表达的影响。方法用MTT法和流式细胞仪检测不同浓度TRAIL蛋白和顺铂(DDP)联合用药对SKOV3细胞生长的影响;化疗药物处理后用RT-PCR方法检测细胞的TRAIL受体(DR4、DR5)表达的变化。结果随着TRAIL蛋白浓度的升高,SKOV3细胞抑制率逐渐升高。TRAIL浓度达到10ng/mL及以上浓度时,TRAIL+DDP联合组的抑制率比TRAIL组明显升高(P<0.05)。流式细胞仪检测SKOV3正常对照组、TRAIL组和TRAIL+DDP组细胞凋亡率分别为5.9%、13.4%、39.5%,各实验组与对照组比较差异有统计学意义(P<0.05),TRAIL蛋白使细胞更多地停留在G0-G1期。RT-PCR检测发现DDP使SKOV3细胞DR5和DR4水平明显升高,分别为对照的1.95倍和1.54倍(P<0.05),而阿霉素、卡铂、5-FU处理后SKOV3细胞DR4、DR5表达无明显改变。结论TRAIL蛋白单独使用对SKOV3细胞生长有抑制作用,肿瘤细胞凋亡率升高,TRAIL与DDP联合使SKOV3细胞抑制率明显升高,促凋亡作用更明显。DDP作用后SKOV3细胞DR4、DR5表达成倍增加。 Objective To investigate the effect of TRAIL on growth and apoptosis of ovarian carcinoma cell line SKOV3. Methods The effects of TRAIL alone and/or associating with DDP to treat on SKOV3 cells growth inhibition were measured by MTT assay, and the changes of DR4 and DR5 mRNA were detected by RT-PCR technique. The cell cycle and apoptosis index were analyzed by technique of Flow Cytometry （FCM）. Results The soluble TRAIL protein had the inhibiting effect on the growth SKOV3 cells. The DDP increased the ability of TRAIL to SKOV3 cell growth inhibition. The apoptotic indexes （AI） of SKOV3 cells detected by FCM were 5.9%, 13.4% and 39.5% for control group, TRAIL group and TRAIL plus DDP group, respectively. The DDP increased the DR5 expressing in SKOV3 cells by 1.95 folds than control group and by 1.54 times for the DR4 expressing than the control group （P〈0. 05）. Conclusions The soluble TRAIL has the effect on inhibiting the growth of SKOV3 cells. The combination use of TRAIL and DDP increases significantly the growth-inhibiting ratio to SKOV3 cells. The AI of SKOV3 cell is raised after TRAIL intervening in. The DDP can increase the expressions of DR4 and DR5 in SKOV3 cells.

作者李春梅彭芝兰尹如铁胡敏

机构地区四川大学华西第二医院妇产科

出处《四川大学学报（医学版）》 CAS CSCD 北大核心 2006年第5期761-764,共4页 Journal of Sichuan University(Medical Sciences)

基金四川大学校青年基金(校200523)资助

关键词卵巢癌 TRAIL 流式细胞仪细胞凋亡 Ovarian neoplasms TRAIL Flow cytometry Apoptosis

分类号 R737.31 [医药卫生—肿瘤]

引文网络
相关文献

参考文献8

1Ashkenazi A,Pai RC,Fong S,et al.Safety and antitumor activity of recombinant soluble Apo2 ligand.J Clin Invest,1999;104(2):155-162.
2Sheridan JP,Marsters SA,Pitti RM,et al.Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors.Science,1997;277(5327):818-821.
3Kassis R,Larrous F,Estaquier J,et al.Lyssavirus matrix protein induces apoptosis by a TRAIL-dependent mechanism involving caspase-8 activation.J Virol,2004;78(12):6543-6555.
4Thomas LR,Henson A,Reed JC,et al.Direct binding of Fas-associated death domain (FADD) to the tumor necrosis factor-related apoptosis-inducing ligand receptor DR5 is regulated by the death effector domain of FADD.J Biol Chem,2004;279(31):32780-32785.
5Guo F,Sigua C,Tao J,et al.Cotreatment with histone deacetylase inhibitor LAQ824 enhances Apo-2L/tumor necrosis factor-related apoptosis inducing ligand-induced death inducing signaling complex activity and apoptosis of human acute leukemia cells.Cancer Res,2004;64(7):2580-2589.
6Abou El,Hassan MA,Mastenbroek DC,et al.Overexpression of Bcl2 abrogates chemo-and radiotherapy-induced sensitization of NCI-H460 non-small-cell lung cancer cells to adenovirus-mediated expression of full-length TRAIL.Br J Cancer,2004;91(1):171-177.
7Arts HJ,de Jong S,Hollema H,et al.Chemotherapy induces death receptor 5 in epithelial ovarian carcinoma.Gynecol Oncol,2004;92(3):794-800.
8Wen J,Ramadevi N,Nguyen D,et al.Antileukemic drugs increase death receptor 5 levels and enhance Apo-2L-induced apoptosis of human acute leukemia cells.Blood,2000;96(12):3900-3906.